Treatments & Interventions
Adrenocorticotropic hormone
substance
Atropine sulfate
substance
Methylprednisolone acetate
substance
Prednisolone acetate
substance
Prednisolone sodium phosphate
substance
Prednisolone tertiary butylacetate
substance
Methylprednisolone
substance
Triamcinolone
substance
Triamcinolone diacetate
substance
Prednisolone
substance
Atropine
substance
Triamcinolone acetonide
substance
Adalimumab
substance
Methylprednisolone sodium succinate
substance
Triamcinolone hexacetonide
substance
Methylprednisolone aceponate
substance
Prednisolone sodium metazoate
substance
Clinical Trials
Recent Trials
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV)
Multicenter Uveitis Steroid Treatment (MUST) Trial
Intestinal Bacteria and Ocular Inflammatory Disease
Adalimumab in JIA-associated Uveitis Stopping Trial
Related Conditions
Quick Facts
- SNOMED CT
- 128473001
- UMLS CUI
- C0042164
- Fully Specified Name
- Uveitis (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 17
- Clinical Trials
- 10
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.